Delhi, India (PRWEB) August 20, 2013
Ken Research has published in the report ‘The US Clinical Research Market Outlook to 2017 – Led by Aging Population and Rise of Chronic Diseases’ the number of registered clinical studies in the US in 2012 were 7,546. The report provides a comprehensive analysis of the various aspects such as market size, segmentation, trends and developments and future projections of the therapeutic areas of Oncology, Central Nervous System Disorders, Cardiovascular Diseases, Infectious Diseases and Metabolic disorders as key segments of the market.
The segment Breast Cancer draws maximum attention and is expected to incline with a CAGR of 22.8% during the period of 2012-2017. Further, the areas of Alzheimer and Multiple Sclerosis are expected to witness new drugs development on account of unmet medical needs in these areas. The market for clinical research in the country showcased a CAGR of 11.7% during 2006-2012 and will witness off shoring of many clinical trials to emergent markets such as China, Latin America and Brazil on account of increasing cost of conducting trials in the US. The market on account of patent expiry of several branded drugs and increased strategic alliances between pharma companies and CRO is projected to escalate with a CAGR of 15.8% during the period of 2012-2017.
“The drug development pipeline for multiple sclerosis is expected to improve. The new drugs such as laquinimod, teriflunomide and dimethyl fumarate, and three mAbs— alemtuzumab, daclizumab and rituximab are anticipated to mask the effects and remit the occurrence of multiple sclerosis” - according to the research report ‘The US Clinical Research Market Outlook to 2017’ from Ken Research
Key Topics Covered:
1. Market Size of US Clinical Research Market
2. Market Segmentation
3. Central Nervous System Clinical Research Market
4. Cardiovascular Clinical Research Market
5. Infectious Diseases Clinical Research Market
6. Metabolic Disorders Clinical Research Market
7. Market Share of Major Players
8. Trends & Developments
9. Future Outlook & Projections
Browse full report:
Other Reports on Healthcare Industry: